Hubungan Derajat Perlemakan Hati Non Alkoholik Menggunakan Pemeriksaan Indeks Hepatorenal Software Image J Pada Ultrasonografi Dengan Peningkatan Kadar Serum Glutamik Pyruvik Transminase Di Rsup Dr. Hasan Sadikin Bandung
Main Article Content
Abstract
Hepatorenal index sonography supported by ImageJ computer software program is one of the ultrasound parameters based on quantitative analysis to address the limitations of ultrasound in the diagnosis and determine the degree of non-alcoholic fatty liver. The degree of non-alcoholic fatty liver is divided into mild, moderate and severe. Increased ALT levels have a close relationship and a predictor of non-alcoholic fatty liver. Increased levels of ALT can influence the degrees of non alcoholic fatty liver. This research aim to determine the relationship between the degree of non alcoholic fatty liver using hepatorenal index J software image on the ultrasound and elevated ALT level in Dr. Hasan Sadikin General Hospital Bandung. This research is an analytic observational study with cross sectional design and concecutive admission sampling to determine the relationship between degree of non alcoholic fatty liver using hepatorenal index J software image on the ultrasound and elevated ALT level Dr. Hasan Sadikin General Hospital from January until March 2017. There are 39 study subjects consisted 22 women and 17 men, the youngest is 29 years old and the oldest is 69 years old. Results of statistical test Chi Square test at the 95% confidence level indicates that the mild non-alcoholic fatty liver mostly revealed on patients with increased ALT levels at the highest limit (100%), moderate non-alcoholic fatty liver mostly found in patients with high ALT levels (63.6%) and in severe non-alcoholic fatty liver can be found in very hight elevated ALT level (50.0%), with p <0.001 (value p ≤ 0,05). There is a significant relationship between degree of non-alcoholic fatty liver using hepatorenal index J software image on the ultrasound and elevated ALT level in Dr. Hasan Sadikin General Hospital Bandung. We conclude that there is a significant relationship between degree of non-alcoholic fatty liver using hepatorenal index J software image on the ultrasound and elevated ALT level in Dr. Hasan Sadikin General Hospital Bandung
Article Details
References
Ahmed M. Non-alcoholic fatty liver disease in 2015. World J Hepatol. 2015 Jun 18;7(11):1450-9.
Review T, LaBrecque DR, Abbas Z, Anania F, Ferenci P, Khan AG, et al. World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J Clin Gastroenterol. 2014 Jul;48(6):467-73.
Fazel Y, Koenig AB, Sayiner M, Goodman ZD, Younossi ZM. Epidemiology and natural history of non-alcoholic fatty liver disease. Metabolism. 2016 Aug;65(8):1017-25.
Hasan I, Gani R, Machmud R. Prevalence and risk factors for nonalcoholic fatty liver in Indonesia. J Gastroenterol Hepatol. 2002;17:154.
Sistem informasi Rumah Sakit. 2010-2015.
Amarapurkar D, Hashimoto E, Lesmana L, Sollano J, Chen P, Goh K. How common is non-alcoholic fatty liver disease in the Asia–Pacific region and are there local differences? Journal of Gastroenterology and Hepatology. 2007;22:788-93.
Lee SS, Park SH. Radiologic evaluation of nonalcoholic fatty liver disease. World J Gastroenterol. 2014 Jun 21;20(23):7392-402.
Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology. 2012 Jun;142(7):1592- 609.
Borges VF, Diniz AL, Cotrim HP, Rocha HL, Andrade NB. Sonographic hepatorenal ratio: a noninvasive method to diagnose nonalcoholic steatosis. J Clin Ultrasound. 2013 Jan;41(1):18-25
AlShaalan R, Aljiffry M, Al-Busafi S, Metrakos P, Hassanain M. Nonalcoholic fatty liver disease: Noninvasive methods of diagnosing hepatic steatosis. Saudi J Gastroenterol. 2015 Mar-Apr;21(2):64-70.
Koplay M, Sivri M, Erdogan H, Nayman A. Importance of imaging and recent developments in diagnosis of nonalcoholic fatty liver disease. World J Hepatol. 2015 Apr 18;7(5):769-76.
Khosravi S, Alavian SM, Zare A, Daryani NE, Fereshtehnejad SM, Daryani NE, et al. Non-alcoholic fatty liver disease and correlation of serum alanin aminotransferase level with histopathologic findings. Hepat Mon. 2011 Jun;11(6):452-8.
Webb M, Yeshua H, Zelber-Sagi S, Santo E, Brazowski E, Halpern Z, et al. Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis. AJR Am J Roentgenol. 2009 Apr;192(4):909-14.
Marshal R, Eissa M, Bluth E, Gulotta P, Davis N. Hepatorenal Index as an Accurate, Simple, and Effective Tool in Screening for Steatosis. Am J Roentgenol. November 2012;199:997-1002.
Martin-Rodriguez JL, Arrebola JP, Jimenez-Moleon JJ, Olea N, Gonzalez- Calvin JL. Sonographic quantification of a hepato-renal index for the assessment of hepatic steatosis in comparison with 3T proton magnetic resonance spectroscopy. Eur J Gastroenterol Hepatol. 2014 Jan;26(1):88- 94.
Saxena T, Arya A. GGT and SGPT - A Rising Marker in Diagnosis of Non-alcoholic Fatty Liver Disease. Biomedical & Pharmacology Journal. 2014;7(1):277-80.
Alvina. Hepatic enzyme concentrations as indicators of nonalcoholic fatty liver disease. Universa Medicena. 2009;28:139-45.
Bi WR, Yang CQ, Shi Q, Xu Y, Cao CP, Ling J, et al. Large-scale analysis of factors influencing nonalcoholic fatty liver disease and its relationship with liver enzymes. Genet Mol Res. 2014 Aug 07;13(3):5880- 91.
Chen Z, Chen L, Dai H, Chen J, Fang L. Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease. . Journal of Zhejiang University. 2008 9(8):616-22.
Obika M, Noguchi H. Diagnosis and evaluation of nonalcoholic fatty liver disease. Exp Diabetes Res. 2012;2012:145754.
Marshall W. Alanine aminotransferase : Serum and Plasma. Association for Clinical Biochemistry 2012.